Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations.
Arabinda DasM AlshareefJ L Martinez SantosG B F PortoD G McDonaldL K InfingerW A VandergriftScott M LindhorstA K VarmaS J PatelDavid CachiaPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
A pre-clinical murine model provides preclinical evidence for use of palbociclib plus radiation as a therapeutic agent for Rb+ meningiomas.